Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-084329
Filing Date
2024-07-31
Accepted
2024-07-31 16:00:36
Documents
5
Effectiveness Date
2024-07-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2420367d1_s8.htm S-8 62719
2 EXHIBIT 5.1 tm2420367d1_ex5-1.htm EX-5.1 7163
3 EXHIBIT 23.2 tm2420367d1_ex23-2.htm EX-23.2 1944
4 EX-FILING FEES tm2420367d1_ex-filingfees.htm EX-FILING FEES 9673
5 GRAPHIC tm2420367d1_ex5-1img01.jpg GRAPHIC 2978
  Complete submission text file 0001104659-24-084329.txt   86943
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281132 | Film No.: 241161795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)